195 related articles for article (PubMed ID: 4282084)
21. Pathophysiology and modern management of Paget's disease.
Ryan WG
Compr Ther; 1983 Sep; 9(9):64-9. PubMed ID: 6226475
[TBL] [Abstract][Full Text] [Related]
22. Newer agents in treating Paget's disease of bone.
Goldfield EB
Geriatrics; 1974 Dec; 29(12):61-9. PubMed ID: 4279196
[No Abstract] [Full Text] [Related]
23. The treatment of Paget's disease.
Berzims D
Aust Nurses J; 1979 Jun; 8(11):34-5. PubMed ID: 157732
[No Abstract] [Full Text] [Related]
24. [Problems in the diagnosis and treatment of Paget's disease].
Zdichynec B
Fysiatr Revmatol Vestn; 1976 Jul; 54(3):113-7. PubMed ID: 134968
[No Abstract] [Full Text] [Related]
25. Calcitonin or mithramycin for Paget's disease.
Russell AS
Lancet; 1980 Apr; 1(8173):884. PubMed ID: 6103247
[No Abstract] [Full Text] [Related]
26. Paget's disease of bone.
Lukert BP
J Kans Med Soc; 1979 Jun; 80(6):345-8. PubMed ID: 156768
[No Abstract] [Full Text] [Related]
27. Dramatic response to plicamycin in a patient with severe Paget's disease refractory to calcitonin and pamidronate.
Wimalawansa SJ
Semin Arthritis Rheum; 1994 Feb; 23(4):267. PubMed ID: 8009249
[No Abstract] [Full Text] [Related]
28. [Treatment of Paget's osteitis deformans].
Brixen K; Steiniche T; Mosekilde L; Melsen F
Ugeskr Laeger; 1989 Mar; 151(11):677-80. PubMed ID: 2522692
[TBL] [Abstract][Full Text] [Related]
29. Osteitis deformans (Paget's disease of bone).
JAMA; 1973 Apr; 224(5 Suppl):782-3. PubMed ID: 4266957
[No Abstract] [Full Text] [Related]
30. 'Breaking the back' of Paget's bone disease.
Ryan WG
Arch Intern Med; 1989 Dec; 149(12):2639. PubMed ID: 2531996
[No Abstract] [Full Text] [Related]
31. [Therapy of Paget's disease].
Silveri F
Clin Ter; 1987 Oct; 123(2):85-94. PubMed ID: 2972476
[No Abstract] [Full Text] [Related]
32. Ten years' treatment for Paget's disease.
Lancet; 1978 Apr; 1(8070):914-5. PubMed ID: 76851
[No Abstract] [Full Text] [Related]
33. [Clinical and metabolic effects of mithramycin and glucagon in the treatment of Paget's disease].
Hadjipavlou AG; Danais S; Greenwood F; Siller TN; Tsoukas GM
Union Med Can; 1978 Sep; 107(9):849-56. PubMed ID: 151960
[No Abstract] [Full Text] [Related]
34. [Management of osteitis deformans--diphosphonate, calcitonin or mitramycin?].
Tørring O
Lakartidningen; 1981 Aug; 78(34):2831-2. PubMed ID: 6459502
[No Abstract] [Full Text] [Related]
35. Calcitonin in the treatment of Paget's disease of bone.
Med Lett Drugs Ther; 1975 Nov; 17(24):97-8. PubMed ID: 1196256
[No Abstract] [Full Text] [Related]
36. Effects of mithramycin and calcitonin in cardiovascular complications of Paget's disease of bone.
Pembrook RC; Chung CH; Carvallo AP
Conn Med; 1975 Apr; 39(4):209-14. PubMed ID: 125180
[No Abstract] [Full Text] [Related]
37. [Therapy of osteodystrophia deformans (Paget's disease)].
Jesserer H
Clin Ter; 1974 Jun; 69(6):501-15. PubMed ID: 4367627
[No Abstract] [Full Text] [Related]
38. Human calcitonin for Paget's disease.
Med Lett Drugs Ther; 1987 May; 29(739):47-8. PubMed ID: 3574238
[No Abstract] [Full Text] [Related]
39. Treatment of Paget's disease of bone.
Melick RA
Med J Aust; 1985 Oct; 143(9):394-7. PubMed ID: 2932626
[No Abstract] [Full Text] [Related]
40. Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP).
De Vries HR; Bijvoet OL
Neth J Med; 1974; 17(6):281-98. PubMed ID: 4280525
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
